logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
CypHer7E Maleimide

CypHer7E maleimide is an excellent building block for developing site-specific pH probes. It can be readily conjugated to thiol-containing biomolecules (such as antibodies, peptides and thiol-modified oligos). It is analogous to CypHer5E maleimide with much longer excitation and emission. It is one of the very few acidotropic pH probes that exhibit NIR fluorescence. CypHer7E is a NIR pH-sensitive cyanine dye derivative that can be used to study most classes of cell surface receptors which internalize into the endocytic pathway when activated by a ligand. CypHer7E maleimide is a flexible, generic fluorophore that can be coupled to a receptor or epitope tag antibody and monitors neutral to acidic intracellular events.

CypHer7E maleimide is an excellent building block for developing site-specific pH probes. It can be readily conjugated to thiol-containing biomolecules (such as antibodies, peptides and thiol-modified oligos). It is analogous to CypHer5E maleimide with much longer excitation and emission.
CypHer7E maleimide is an excellent building block for developing site-specific pH probes. It can be readily conjugated to thiol-containing biomolecules (such as antibodies, peptides and thiol-modified oligos). It is analogous to CypHer5E maleimide with much longer excitation and emission.
CatalogSize
Price
Quantity
219151 mg
Price
 
Physical properties

Molecular weight890.94
SolventDMSO
Spectral properties

Excitation (nm)748
Emission (nm)769
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 5, 2025